MedTrace Logo

Genomic Sequencing and Personalized Treatment for Birth Defects in Neonatal Intensive Care Units

NCT02551081 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2025-09-05

No results posted yet for this study

Summary

The purpose of study is to evaluate the benefits of using the Next Generation Sequencing Technology to diagnose birth defects and genetic diseases. The results from genomic sequencing can also significantly shorten the time of examination, improve the diagnosis rate, guide the clinical treatments. So the ultimate goal is individualized or personalized therapy and promote prognosis.

Conditions

Sponsors & Collaborators

  • Xiamen Children's Hospital, Fujian of China

    collaborator OTHER

  • Maternal and Child Health Hospital of Guangxi Zhuang Autonomous Region

    collaborator OTHER

  • Guangzhou Women and Children's Medical Center

    collaborator OTHER

  • Second Affiliated Hospital of Wenzhou Medical University

    collaborator OTHER

  • Maternal and Child Health Hospital of Hubei Province

    collaborator OTHER

  • The Maternal & Children Health Hospital of Dehong, Yunnan of China

    collaborator OTHER

  • Children's Hospital of Fudan University

    lead OTHER

Principal Investigators

  • Wenhao Zhou, Doctor · Children's Hospital of Fudan University

Eligibility

Max Age
28 Days
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-10-01
Primary Completion
2025-12-30
Completion
2025-12-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02551081 on ClinicalTrials.gov